(1) About Genius® 3D Mammography™ exams:
The Genius® 3D Mammography™ exam allows your doctor to examine your breast tissues layer by layer. So, instead of viewing all of the complexities of your breast tissue in a flat image, like with traditional 2D mammography, fine details are more visible and no longer hidden by the tissue above or below. This level of precision gives your doctor the confiden
ce and clarity to reduce false positives and your chances to be called back for additional screening by up to 40%. (2-3) The best part? The Genius® exam is the only mammogram FDA-approved as a superior for women with dense breasts. (4-5)
About Hologic:
Hologic is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. We bring The Science of Sure to life by providing healthcare professionals with groundbreaking diagnostic tools, allowing them to make life-affirming and, in many cases, life-saving decisions. The Genius® 3D™ exam has revolutionized breast cancer screening and detection for women of all ages and breast density around the world. Speak to your doctor today and ask if they offer the Genius® 3D Mammography™ exam because you deserve the very best!
1. Results from Friedewald, SM, et al. "Breast cancer screening using
tomosynthesis in combination with digital mammography." JAMA 311.24
(2014): 2499-2507; a multi-site (13), non-randomized, historical control
study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia® Dimensions ® on screening outcomes. Individual results may vary. The study found an average 41% (95% CI: 20-65%) increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3DTM mammograms acquired with the Hologic 3D MammographyTM System versus women receiving 2D FFDM mammograms only. 2. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507. 3. Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13. 4. JAMA. 2014 Jun 25;311(24):2499-507. 5. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D(TM) mammograms acquired with the Hologic 3D Mammography(TM) System versus women receiving 2D FFDM mammograms only.
